| 000 | 01358 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515211454.0 | ||
| 264 | 0 | _c20100617 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656560903575639 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchima, Susan M | |
| 245 | 0 | 0 |
_aFibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cApr 2010 |
||
| 300 |
_a731-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aDyslipidemias _xcomplications |
| 650 | 0 | 4 |
_aFenofibrate _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xadverse effects |
| 700 | 1 | _aMaciejewski, Stephanie R | |
| 700 | 1 | _aHilleman, Daniel E | |
| 700 | 1 | _aWilliams, Mark A | |
| 700 | 1 | _aMohiuddin, Syed M | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 11 _gno. 5 _gp. 731-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656560903575639 _zAvailable from publisher's website |
| 999 |
_c19577829 _d19577829 |
||